PICHINI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.389
EU - Europa 777
AS - Asia 228
AF - Africa 39
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.440
Nazione #
US - Stati Uniti d'America 2.384
IT - Italia 188
IE - Irlanda 163
SE - Svezia 129
CN - Cina 103
UA - Ucraina 103
SG - Singapore 72
DE - Germania 66
GB - Regno Unito 45
CI - Costa d'Avorio 36
IN - India 30
BE - Belgio 23
FI - Finlandia 22
AT - Austria 9
FR - Francia 7
DK - Danimarca 6
AU - Australia 5
GE - Georgia 5
TR - Turchia 5
CH - Svizzera 4
JP - Giappone 4
PL - Polonia 4
KR - Corea 3
CA - Canada 2
NL - Olanda 2
PA - Panama 2
PH - Filippine 2
RU - Federazione Russa 2
TH - Thailandia 2
ZA - Sudafrica 2
EU - Europa 1
IL - Israele 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
PE - Perù 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 3.440
Città #
Chandler 358
Des Moines 263
Fairfield 237
Jacksonville 182
Ashburn 168
Dublin 163
Wilmington 109
Houston 104
Woodbridge 101
Seattle 99
Cambridge 87
Lawrence 62
Princeton 62
San Mateo 51
Ann Arbor 49
New York 46
Turin 37
Abidjan 36
Boardman 32
London 22
Pune 22
San Diego 22
Helsinki 21
Rome 19
Washington 18
Brussels 17
Singapore 15
Milan 13
Centro 11
Los Angeles 11
Falls Church 10
Beijing 9
Kilburn 9
Norwalk 9
Shanghai 9
Vienna 9
Guangzhou 7
Jinan 7
Mohali 7
Tolentino 7
Wuhan 7
Ancona 6
Boydton 5
Shenzhen 5
Tbilisi 5
Civitanova Marche 4
Hrebenne 4
Redwood City 4
Wandsworth 4
Brisbane 3
Hounslow 3
Izmir 3
Messina 3
Quanzhou 3
Santa Clara 3
Tokyo 3
Yiwu 3
Adelaide 2
Agugliano 2
Amsterdam 2
Ashville 2
Bangkok 2
Birmingham 2
Carisio 2
Chions 2
Copenhagen 2
Frankfurt Am Main 2
Frankfurt am Main 2
Heze 2
Islington 2
Istanbul 2
Jinhua 2
Lausanne 2
Legaspi Port 2
Marche 2
Modena 2
Montesilvano Marina 2
Panama City 2
Perugia 2
Pesaro 2
Redmond 2
Seoul 2
Wuxi 2
Zibo 2
Aarhus 1
Atlanta 1
Chicago 1
Como 1
Dalian 1
Dallas 1
Dongyang 1
Eugene 1
Fayetteville 1
Forest City 1
Frederiksberg 1
Guadalajara 1
Hangzhou 1
Hyderabad 1
Il-Madliena 1
Jiaxing 1
Totale 2.658
Nome #
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis" 92
Toxicology and analysis of psychoactive tryptamines 89
Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy 81
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid 79
European drug users at risk from illicit fentanyls mix 79
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis 78
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 75
Herbal preparations of medical cannabis: A vademecum for prescribing doctors 74
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 71
Monitoring Prenatal Exposure to Buprenorphine and Methadone 70
Measurement uncertainty in forensic toxicology 69
Cannabidiol adverse effects and toxicity 67
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 67
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 66
Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual 65
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 65
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 64
Correspondence 64
Commentary - Heroin purity and adulteration: An updated snapshot from the Italian Early Warning System 63
Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analysis of psychoactive drugs in oral fluid 61
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use 61
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 61
Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS 61
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases 60
Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry 60
Synthetic cathinones related fatalities: an update 57
Pharmacology and legal status of cannabidiol 57
Analytical advances in clinical and forensic toxicology. Second part 56
Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis 56
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update 53
Metabolic pathways and potencies of new fentanyl analogs 53
Comment on "direct Monitoring of Exogenous γ-Hydroxybutyric Acid in Body Fluids by NMR Spectroscopy": Several Issues to Consider When Quantifying γ-Hydroxybutyric Acid in Biological Matrixes 52
Advances and future developments in forensic toxicology: From standard practices to new psychoactive substances 51
Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: A pilot study 51
Nails analysis for drugs used in the context of chemsex: A pilot study 50
Clarifying methodological issues in cannabinoids determination in bronchoalveolar lavages 49
The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report 49
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone 49
Medicinal cannabis and synthetic cannabinoid use 45
Ultra-high-performance liquid chromatography tandem mass spectrometry assay for determination of endogenous ghb and ghb-glucuronide in nails 44
Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease 44
Editorial: The challenge posed by new synthetic opioids: Pharmacology and toxicology 44
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 44
Pharmacotoxicology of non-fentanyl derived new synthetic opioids 40
Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry 39
GHB concentration in breast milk of narcoleptic women treated with sodium oxybate. How important it is to be careful when interpreting values 39
Editorial: Analytical Advances in Clinical and Forensic Toxicology 39
New psychoactive substances: A matter of time 39
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices 38
Cannabis: Neurological correlates in abuse and medical use 38
Global prevalence of fetal alcohol spectrum disorder in Italy 38
Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study 37
GHB side effects: The need to clearly document drug dose and administration history 36
The issue of psychotropic drug monitoring in sexual assault victims 35
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 35
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 34
Acute pharmacological effects and oral fluid biomarkers of the synthetic cannabinoid ur-144 and thc in recreational users 34
Nails in Forensic Toxicology: an Update 33
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis 30
Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans 30
Herbal highs: Review on Psychoactive Effects and Neuropharmacology 30
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 30
The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances 29
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs 20
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 18
Molecular Insights on New Psychoactive Substances (NPSs) 18
Pharmacological effects of methylone and MDMA in humans 15
The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine 13
null 12
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid 10
Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis 9
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 7
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 7
Erratum to Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 6, June 2023, 100944 7
GHB-facilitated sexual assaults: How to proper assess a single GHB exposure in hair 7
Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH 6
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 6
Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes 5
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users 5
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 5
Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis 5
A “special dose” of ethics in forensic toxicology 5
Targeted screening and quantification of synthetic cathinones and metabolites in hair by UHPLC-HRMS 5
null 5
Editorial: Drug-drug interactions in pharmacology 4
Molecular Insights of New Psychoactive Substances (NPS) 2.0 4
Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties 3
Target Analysis of NPS in Oral Fluid 3
Analytical procedures and blood threshold values to ascertain driving in a stae of psycho-physical impairment from drugs abuse|Procedure analitiche e valori decisionali ematici per accertare la guida in stato di alterazione psicofisica da sostanze d'abuso 3
Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids 2
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 2
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy. 2
NPS–EQA PART II: Four years’ experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in hair 2
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance 1
Totale 3.565
Categoria #
all - tutte 24.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 10 1 0 1 27 7 38 8 35 0 20 55
2020/2021890 55 51 79 3 55 64 120 117 79 79 85 103
2021/2022467 39 61 19 7 4 46 4 30 49 38 60 110
2022/20231.198 97 130 85 79 49 343 16 69 226 3 82 19
2023/2024664 86 14 86 58 92 131 26 22 10 21 25 93
2024/202596 96 0 0 0 0 0 0 0 0 0 0 0
Totale 3.565